Tumor-Targeted miRNA Nanomedicine for Overcoming Challenges in Immunity and Therapeutic Resistance
- 1 August 2022
- journal article
- review article
- Published by Taylor & Francis in Nanomedicine
- Vol. 17 (19) , 1355-1373
Abstract
MiRNA are critical messengers in the tumor microenvironment (TME) that influence various processes leading to immune suppression, tumor progression, metastasis and resistance. Strategies to modulat... Plain language summary miRNAs are the messenger molecules with the tumor that have significant influence on the cancer growth and progression. Many strategies have been evaluated to modulate these ... Graphical abstractKeywords
Funding Information
- Center for Strategic Scientific Initiatives, National Cancer Institute (R21-CA213114, R56-CA198492)
This publication has 174 references indexed in Scilit:
- Mesenchymal stem cells engineered for cancer therapyAdvanced Drug Delivery Reviews, 2012
- The role of mesenchymal stem cells in anti-cancer drug resistance and tumour progressionBritish Journal of Cancer, 2012
- RETRACTED ARTICLE: EGFR and MET receptor tyrosine kinase–altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancersNature Medicine, 2011
- Let‐7 modulates acquired resistance of ovarian cancer to TaxanesviaIMP‐1‐mediated stabilization of multidrug resistance 1International Journal of Cancer, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cellsBiochemical Pharmacology, 2008
- β-Sheet Pore-Forming Peptides Selected from a Rational Combinatorial Library: Mechanism of Pore Formation in Lipid Vesicles and Activity in Biological MembranesBiochemistry, 2007
- A microRNA component of the p53 tumour suppressor networkNature, 2007
- A microRNA polycistron as a potential human oncogeneNature, 2005
- The Hallmarks of CancerCell, 2000